1. RODNA
  2. CIC Digital
  3. Comisión de Investigaciones Científicas de la Prov. de Buenos Aires
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.provenanceComisión de Investigaciones Científicas-
dc.contributorAbba, Martín Carlos-
dc.contributorLacunza, Ezequiel-
dc.contributorNunez, M. I.-
dc.contributorColussi, Andrea G.-
dc.contributorIsla Larrain, Marina Teresita-
dc.contributorSegal Eiras, Amada-
dc.contributorCroce, María Virginia-
dc.contributorAldaz, C. Marcelo-
dc.creatorAbba, Martín Carlos-
dc.creatorLacunza, Ezequiel-
dc.creatorNunez, M. I.-
dc.creatorColussi, Andrea G.-
dc.creatorIsla Larrain, Marina Teresita-
dc.creatorSegal Eiras, Amada-
dc.creatorCroce, María Virginia-
dc.creatorAldaz, C. Marcelo-
dc.date2009-10-
dc.date.accessioned2019-04-29T16:08:38Z-
dc.date.available2019-04-29T16:08:38Z-
dc.date.issued2009-10-
dc.identifierhttp://digital.cic.gba.gob.ar/handle/11746/6172-
dc.identifierRecurso completo-
dc.identifier.urihttp://rodna.bn.gov.ar:8080/jspui/handle/bnmm/310226-
dc.descriptionIn the course of breast cancer global gene expression studies, we identified an uncharacterized gene known as RHBDD2 (Rhomboid domain containing 2) to be markedly over-expressed in primary tumors from patients with recurrent disease. In this study, we identified RHBDD2 mRNA and protein expression significantly elevated in breast carcinomas compared with normal breast samples as analyzed by SAGE (n=46) and immunohistochemistry (n=213). Interestingly, specimens displaying RHBDD2 over-expression were predominantly advanced stage III breast carcinomas (p=0.001). Western-blot, RT-PCR and cDNA sequencing analyses allowed us to identify two RHBDD2 alternatively spliced mRNA isoforms expressed in breast cancer cell lines. We further investigated the occurrence and frequency of gene amplification and over-expression affecting RHBDD2 in 131 breast samples. RHBDD2 gene amplification was detected in 21% of 98 invasive breast carcinomas analyzed. However, no RHBDD2 amplification was detected in normal breast tissues (n=17) or breast benign lesions (n=16) (p=0.014). Interestingly, siRNA mediated silencing of RHBDD2 expression results in a decrease of MCF7 breast cancer cells proliferation compared with the corresponding controls (p=0.001). In addition, analysis of publicly available gene expression data showed a strong association between high RHBDD2 expression and decreased overall survival (p=0.0023), relapsefree survival (p= 0.0013), and metastasis-free interval (p=0.006) in patients with primary ERnegative breast carcinomas. In conclusion, our findings suggest that RHBDD2 over-expression behaves as an indicator of poor prognosis and may play a role facilitating breast cancer progression.-
dc.formatapplication/pdf-
dc.formatp. 988–997-
dc.languageeng-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.rightsAttribution-ShareAlike 4.0 International (BY-SA 4.0)-
dc.sourcereponame:CIC Digital (CICBA)-
dc.sourceinstname:Comisión de Investigaciones Científicas de la Provincia de Buenos Aires-
dc.sourceinstacron:CICBA-
dc.source.urihttp://digital.cic.gba.gob.ar/handle/11746/6172-
dc.source.uriRecurso completo-
dc.subjectCiencias Médicas-
dc.titleRhomboid domain containing 2 (RHBDD2): A novel cancer-related gene over-expressed in breast cancer-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/submittedVersion-
dc.typeinfo:ar-repo/semantics/articulo-
Aparece en las colecciones: Comisión de Investigaciones Científicas de la Prov. de Buenos Aires

Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Mostrar el registro sencillo del ítem